Cilostazol

What is Cilostazol?

Cilostazol is a medication primarily prescribed to improve symptoms of intermittent claudication, a common and often debilitating symptom of peripheral artery disease (PAD). It belongs to a class of drugs known as phosphodiesterase-3 (PDE3) inhibitors. As such, it works by both dilating blood vessels and inhibiting platelet aggregation. This dual action helps to increase blood flow to the legs, thereby reducing the pain and cramping experienced by individuals with PAD during physical activity. Available as an oral tablet, Cilostazol is an important therapeutic option for patients seeking to enhance their walking ability and overall quality of life when conservative measures like exercise and lifestyle changes are insufficient.

How Does it Work?

The therapeutic efficacy of Cilostazol stems from its unique mechanism of action as a selective phosphodiesterase-3 inhibitor. By inhibiting the PDE3 enzyme, Cilostazol prevents the breakdown of cyclic adenosine monophosphate (cAMP) within cells. The increased levels of cAMP lead to two primary beneficial effects. Firstly, it promotes vasodilation, particularly in the arterial beds of the legs, by relaxing the smooth muscle cells in the blood vessel walls. This widening of the blood vessels significantly improves blood flow to the muscles, which are often deprived of oxygen during exertion in patients with peripheral artery disease. Secondly, increased cAMP levels inhibit platelet aggregation, making platelets less likely to stick together and form clots that could further impede blood circulation. These combined effects contribute to a reduction in ischemic pain and an increase in pain-free walking distance for patients with intermittent claudication.

Medical Uses

The primary medical use of Cilostazol is the symptomatic treatment of intermittent claudication in patients with peripheral artery disease (PAD). Intermittent claudication is characterized by pain, cramping, or discomfort in the leg muscles that occurs during exercise and is relieved by rest. This symptom arises from insufficient blood flow to the leg muscles due to narrowed or blocked arteries. Cilostazol is not a cure for PAD but is effective in improving the walking distance and reducing the frequency and severity of claudication symptoms. It is typically prescribed as an adjunct to lifestyle modifications, such as regular exercise, smoking cessation, and dietary changes, which are crucial for managing PAD. While its main indication is claudication, its antiplatelet properties have also been explored in other vascular conditions, though its use is predominantly focused on improving functional outcomes for PAD patients.

Dosage

The standard recommended oral dosage for Cilostazol is 100 mg twice daily, taken at least 30 minutes before or 2 hours after breakfast and dinner. This timing is crucial because food, especially high-fat meals, can increase the absorption of Cilostazol, potentially leading to higher plasma concentrations and an increased risk of side effects. For some patients, particularly those who experience side effects, a lower dose of 50 mg twice daily may be initiated and gradually increased. It's important to note that the full therapeutic effect of Cilostazol may not be observed for several weeks or even up to 12 weeks of continuous treatment. Patients should adhere strictly to their doctor's instructions regarding dosage and administration. Dose adjustments may be necessary in patients with renal or hepatic impairment, and concurrent use of certain medications can also necessitate a lower dose.

Side Effects

Like all medications, Cilostazol can cause side effects, though not everyone experiences them. Common side effects often include headache, diarrhea, abnormal stools, palpitations, dizziness, and peripheral edema (swelling in the ankles or feet). These are usually mild to moderate and may diminish with continued use. More serious, but less common, side effects can include tachycardia (fast heart rate), angina pectoris (chest pain), and increased risk of bleeding due to its antiplatelet effect. Patients should be advised to report any unusual bleeding or bruising to their doctor. Cilostazol is contraindicated in patients with heart failure of any severity, as it has been shown to worsen the prognosis in such cases. Patients with a history of heart attack, stroke, or severe kidney or liver disease should use Cilostazol with caution and under strict medical supervision. Any persistent or severe side effects should prompt immediate consultation with a healthcare professional.

Drug Interactions

Cilostazol metabolism involves cytochrome P450 (CYP) enzymes, particularly CYP3A4 and CYP2C19, making it susceptible to various drug interactions. Concomitant use with strong inhibitors of these enzymes can significantly increase Cilostazol plasma concentrations, thereby escalating the risk of side effects. Examples include CYP3A4 inhibitors like ketoconazole, erythromycin, diltiazem, and grapefruit juice, and CYP2C19 inhibitors such as omeprazole. In such cases, a dose reduction of Cilostazol to 50 mg twice daily may be necessary. Furthermore, due to its antiplatelet properties, combining Cilostazol with other antiplatelet agents (e.g., aspirin, clopidogrel) or anticoagulants (e.g., warfarin, heparin) can increase the risk of bleeding. Patients should inform their doctor about all prescription, over-the-counter, and herbal supplements they are taking to avoid potentially harmful interactions and ensure safe and effective treatment with Cilostazol.

FAQ

• What is Cilostazol primarily used for?

  Cilostazol is primarily used to improve the symptoms of intermittent claudication, which is leg pain caused by poor blood circulation in the legs, a common symptom of peripheral artery disease (PAD).

• How long does it take for Cilostazol to work?

  While some patients may notice improvements earlier, the full therapeutic effects of Cilostazol, such as increased walking distance, may take up to 12 weeks of consistent treatment to become apparent.

• Is Cilostazol a blood thinner?

  Yes, Cilostazol has antiplatelet properties, meaning it inhibits platelet aggregation and can reduce the blood's ability to clot. This effect contributes to its ability to improve blood flow, but also increases the risk of bleeding.

• Can I drink alcohol while taking Cilostazol?

  Moderate alcohol consumption is generally not contraindicated, but it's always best to discuss alcohol intake with your doctor. Excessive alcohol can exacerbate some side effects like dizziness or headache, and may also increase the risk of gastrointestinal bleeding.

• What should I do if I miss a dose?

  If you miss a dose of Cilostazol, take it as soon as you remember, unless it is almost time for your next scheduled dose. In that case, skip the missed dose and continue with your regular dosing schedule. Do not double doses to make up for a missed one.

Products containing Cilostazol are available through trusted online pharmacies. You can browse Cilostazol-based medications at ShipperVIP or Medicenter.

Summary

Cilostazol is an effective medication for managing the symptoms of intermittent claudication associated with peripheral artery disease. Through its dual action of vasodilation and platelet aggregation inhibition, it significantly improves blood flow to the legs, allowing patients to walk further with less pain. While generally well-tolerated, it is crucial to be aware of potential side effects and drug interactions, especially with other antiplatelet or anticoagulant medications. Adherence to prescribed dosage and close consultation with a healthcare provider are essential for maximizing the benefits and minimizing the risks associated with Cilostazol therapy, ultimately enhancing the quality of life for individuals living with PAD.